Jasper Therapeutics Stock Jumps on Positive Asthma Drug Results
Jasper Therapeutics (JSPR) shares rise 60% after experimental drug briquilimab shows promising results in early-stage asthma study, improving lung function and reducing inflammation.
NOTRELOAD AI
Morgan Stanley Issues Key Rating Changes Across MedTech and Healthcare Stocks
Morgan Stanley updates ratings for Inspire Medical, DexCom, and Bausch + Lomb, highlighting slowing growth, improving operations, and strong long-term pipelines.
Truist Upgrades Six Flags on New CEO and Private Equity Interest
Truist upgrades Six Flags to Buy, citing a promising new CEO, potential private-equity interest, and reduced bankruptcy concerns.
Netflix Ups Bid for Warner Bros. Discovery as Streaming Wars Heat Up
Netflix (NFLX) submits improved cash offer for WBD assets, competing against Paramount (PSKY) and Comcast (CMCSA) in major streaming industry consolidation battle.
TD Cowen Starts Coverage on C4 Therapeutics with a Buy Rating
TD Cowen initiates C4 Therapeutics with a Buy rating, highlighting its strong clinical validation in targeted protein degradation and the potential of Cemsi as a "backbone therapy" for multiple myeloma.
Credo Tech Q2 Profit Triples on AI Boom, Stock Surges
Credo Technology (CRDO) swings to $82.6M profit as Q2 revenue triples to $268M, driven by AI infrastructure demand. Stock jumps 15% on strong outlook.